van der Meulen, M., Zamanipoor Najafabadi, A. H., Lobatto, D. J., Andela, C. D., Vliet Vlieland, T. P. M., Pereira, A. M., . . . Biermasz, N. R. (2020). SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements. Endocrine.

van der Meulen, Merel, Amir H. Zamanipoor Najafabadi, Daniel J. Lobatto, Cornelie D. Andela, Thea P. M. Vliet Vlieland, Alberto M. Pereira, Wouter R. van Furth, ja Nienke R. Biermasz. "SF-12 or SF-36 in Pituitary Disease? Toward Concise and Comprehensive Patient-reported Outcomes Measurements." Endocrine 2020.

van der Meulen, Merel, et al. "SF-12 or SF-36 in Pituitary Disease? Toward Concise and Comprehensive Patient-reported Outcomes Measurements." Endocrine 2020.